HomePortfoliosSnP50 + Emerging50

SnP50 + Emerging50

None Rebalancing
EUR
Moderate Risk
0.4yr backtest

Performance Summary

Total Return+11.00%
Annualized Return+28.93%
Volatility+17.89%
Sharpe Ratio1.50
Max Drawdown+7.79%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
Diversified ETF portfolio equally split between US S&P 500 and Emerging Markets equities for broad global growth exposure.
AssetTypeAllocationTER
SPYL.XETRA
State Street SPDR S&P 500 UCITS ETF USD Unhedged (Acc)IE000XZSV718
ETF
50.0%0.03%
LEMA.XETRA
Amundi Core MSCI Emerging Markets Swap UCITS ETF AccLU2573967036
ETF
50.0%0.14%
Total100.0%0.09%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €11,099.87
Histogram of Monthly Returns
The portfolio had a positive return during 4 of the 6 months (67%)
Monthly Returns Heatmap
Best month: +11.0% • Worst month: -6.6% • Best year: 2026 (+11.0%) • Worst year: 2026 (+11.0%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-+1.9%-6.6%+11.0%+7.7%+1.3%-3.8%-----+11.0%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +7.79% • The longest drawdown period lasted for 1 month and was between February 2026 and April 2026. It reached a trough of -7.8%.

Detailed Metrics

Returns
Total Return
+11.00%
Annualized Return
+28.93%
Avg Monthly Return
+1.93%
Risk
Volatility (Annual)
+17.89%
Max Drawdown
+7.79%
Positive Months
67%
Average Drawdown
-2.9%
Risk-Adjusted
Sharpe Ratio
1.50
Risk-free rate: 2.0%
Sortino Ratio
1.59
Downside risk adjusted
Return/Volatility
1.62
Calmar Ratio
3.71
Return/Max Drawdown
Ulcer Index
3.08
Drawdown depth & duration
Martin Ratio
0.09
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
11,099.87
Backtest Period
2026-02-17 to 2026-07-17
0.4 years
Rebalancing
none
Base Currency
EUR
SnP50 + Emerging50 | +28.9% CAGR | ETF Backtest